Premature Infants with Biliary Atresia, a Nationwide Cohort Analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON21672

Enrollment

Registered

2016-10-18

Start date

2016-10-18

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Describe the incidence and course of disease in premature infants with biliary atresia

Interventions

None

Eligibility

Inclusion criteria

Inclusion criteria: All premature infants treated for BA in the UMCG between 1987 and 2016

Exclusion criteria

Exclusion criteria: No treatment for BA, no premee.

Design outcomes

Primary

Measure	Time frame
Native liver survival, clearance of jaundice, mortality	—

Secondary

Measure	Time frame
Presence of congenital anomalies, age at onset of jaundice, age at onset of pale stool, age at presentation in first (community) hospital, referral interval (defined as days between presentation at first (community) hospital and KPE), age at KPE, corrected age at KPE,	—

Contacts

Public ContactDaan BE van Wessel

Parkweg 105

d.b.e.van.wessel@umcg.nl00316 40 61 16 61

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)